December 2, 2019
Fulbright scholar to present anti-rabies virus research and share Fulbright experience and Indian culture
Rudramurthy Renukaiah, a Fulbright Nehru postdoctoral fellow at the Centers for Disease Control and Prevention in Atlanta, will discuss his research work on screening and characterization of small molecule inhibitors against rabies virus, as well as share his Fulbright experience and Indian culture at 4 p.m. Tuesday, Dec. 3, in 324 Ackert Hall.
Renukaiah worked as a research scholar at the International Committee for Animal Recording — National Institute of Veterinary Epidemiology and Disease Informatics, in Bengaluru, India, and obtained his doctorate in biotechnology from Jawaharlal Nehru Technological University in Hyderabad, India. He has more than 18 years of teaching and research experience in the fields of molecular diagnostics, and virology.
Renukaiah's project at the CDC is focused on the advanced strategy in the development of inhibitors against rabies virus. Rabies has the highest case fatality rate for any etiological agent. Currently, there is no approved anti-viral drug specific against rabies virus to treat patients after the viral infection has started.